MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,119,394 | -10.2% | 278,223 | -25.5% | 0.14% | -11.2% |
| Q2 2023 | $13,488,485 | +36.3% | 373,332 | +40.3% | 0.16% | +18.5% |
| Q1 2023 | $9,893,598 | -65.7% | 266,100 | -58.2% | 0.14% | -65.0% |
| Q4 2022 | $28,849,647 | +85.6% | 636,717 | +186.2% | 0.39% | +77.9% |
| Q3 2022 | $15,540,000 | -21.1% | 222,508 | -24.2% | 0.22% | -28.6% |
| Q2 2022 | $19,707,000 | +90.1% | 293,567 | +132.9% | 0.30% | +81.0% |
| Q1 2022 | $10,364,000 | -43.4% | 126,048 | +0.9% | 0.17% | -35.9% |
| Q4 2021 | $18,320,000 | -8.5% | 124,892 | +10.4% | 0.26% | -19.9% |
| Q3 2021 | $20,016,000 | +31.4% | 113,143 | +20.0% | 0.33% | +15.1% |
| Q2 2021 | $15,228,000 | +185.8% | 94,276 | +203.1% | 0.28% | +140.7% |
| Q1 2021 | $5,328,000 | -9.8% | 31,103 | -39.9% | 0.12% | -49.6% |
| Q2 2020 | $5,907,000 | -23.9% | 51,742 | -48.7% | 0.23% | -57.8% |
| Q1 2020 | $7,760,000 | – | 100,953 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |